↓ Skip to main content

Dove Medical Press

Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy

Overview of attention for article published in Biologics: Targets & Therapy, April 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#13 of 274)
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
2 news outlets
twitter
7 X users
patent
2 patents

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
133 Mendeley
Title
Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
Published in
Biologics: Targets & Therapy, April 2021
DOI 10.2147/btt.s291768
Pubmed ID
Authors

Elizabeth R Hawkins, Reena R D’Souza, Astero Klampatsa

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 133 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 133 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 11%
Student > Ph. D. Student 13 10%
Student > Bachelor 13 10%
Researcher 8 6%
Other 7 5%
Other 15 11%
Unknown 63 47%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 21 16%
Immunology and Microbiology 18 14%
Medicine and Dentistry 7 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Agricultural and Biological Sciences 3 2%
Other 13 10%
Unknown 66 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2024.
All research outputs
#1,873,825
of 25,584,565 outputs
Outputs from Biologics: Targets & Therapy
#13
of 274 outputs
Outputs of similar age
#50,109
of 455,251 outputs
Outputs of similar age from Biologics: Targets & Therapy
#3
of 10 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 274 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,251 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.